drugset / Trial / NCT00025272
Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Phase 2
Completed
14 enrolled
Wake Forest University Health Sciences
National Cancer Institute (NCI) · collab
Open-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving them in different ways may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining topotecan, carboplatin, and etoposide in treating patients who have extensive-stage small cell lung cancer.
Timeline
- Start
- 2001-11-01
- Primary completion
- 2005-01-18
- Completion
- 2005-01-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | — | Intravenous |
| Subject | Etoposide | Small molecule | — | Oral |
| Subject | Topotecan | Small molecule | — | Oral |